Khalaf Michel reported option exercise involving 94,578 derivative units of METLIFE INC at $0.00 for $0 on Nov 10, 2026

Option exercise
Form 4 code M. Exercise or conversion of a derivative security exempt under Rule 16b-3.
President & CEO
President & CEO
Filed Nov 12, 2026

Facts from the filing

Form 4 · Derivative, table II
Disclosed value
$0Shares × reported price
Shares traded
94,578Employee Stock Option (Right to Buy)
Price per share
$0.00Reported price. Read footnotes for ranges.
% of reported position traded
UnavailableThis security and ownership context
Holdings after
0Direct
Trade date
Nov 10, 2026Option exercise
Filed
Nov 12, 2026, 4:23 PM ET2-day reporting delay
Accession
0001535491-26-000007Code M · Transaction 398964
How reported position traded is calculated

Not calculated for derivative securities.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

Other trades in this filing

Trade dateActivitySharesPriceValueDetails
Nov 10, 2026Sell187,425$102.97−$19,298,702.43Trade 398960
Nov 10, 2026Option exercise28,817$0.00$0Trade 398961
Nov 10, 2026Option exercise34,608$0.00$0Trade 398962
Nov 10, 2026Option exercise90,726$0.00$0Trade 398963
Nov 10, 2026Option exercise28,817$46.85$1,350,076.45Trade 398956
Nov 10, 2026Option exercise34,608$45.50$1,574,664Trade 398957
Nov 10, 2026Option exercise90,726$44.65$4,050,915.90Trade 398958
Nov 10, 2026Option exercise94,578$47.58$4,500,021.24Trade 398959
9 transaction rows in this filing. Joint filers share the same rows.

MET price since this filing

Daily closing prices, with the filing date and available return windows. Return methodology
MET · Daily closing priceDaily price data is pending. The chart appears when valid daily closes are available.
Filing dateReturn windows appear as prices become available.

Return windows are pending. The first 7-day window is eligible on Nov 19, 2026. Values appear when the daily price refresh supplies a valid close for that window. Weekends, market holidays and missing prices can delay updates.

Pre-filing1mo ago −2.3%1w ago 0%1d ago 0%
Returns since7d30d90d180d1y

Footnotes in full

F1: The reporting person sold only the number of shares of MetLife, Inc.'s common stock necessary to pay the exercise price of the options exercised on November 10, 2026, and related tax obligations and fees. F2: The price reported is the weighted average price of the aggregate number of shares sold in multiple open market transactions. The shares were sold at prices between $102.59 to $103.235, inclusive. The reporting person undertakes to provide to the staff of the SEC, MetLife, Inc., or a security holder of the Issuer, upon request, full information regarding the number of shares purchased at each separate price. F3: Includes 3,073 stock options previously added to the reporting person's award through an adjustment to maintain the intrinsic value of the stock options in light of the distribution by MetLife, Inc. to its shareholders of Brighthouse Financial, Inc. common stock. The reporting person did not receive shares of Brighthouse Financial, Inc. common stock on account of the stock options. F4: The options became exercisable in three equal installments on February 28, 2018, 2019, and 2020. F5: The options became exercisable in three installments on March 2, 2019, 2020 and 2021. F6: The options became exercisable in three installments on February 26, 2020, 2021 and 2022. F7: The options become exercisable in equal installments on each of the first three anniversaries of the grant date.